Registration is now open for SSO 2022 – International Conference on Surgical Cancer Care in Dallas, TX, March 9 – 12, 2022. The Scientific Program Committee is formalizing the program schedule, which will provide ample opportunities for networking with colleagues and old friends in the SSO HUB.
SSO’s primary focus is the health and wellness of all meeting attendees. We are committed to following all COVID-19 CDC Guidelines to help ensure an environment that is safe. Additional information regarding the management of COVID-19 safety practices will be updated on an ongoing basis.
Advanced Cancer Therapies meeting will take place in Dallas, March 11 – March 12, 2022. This meeting-in-a-meeting concept will provide new opportunities for attendees to attend both meetings – one registration fee provides access to all educational content.
Abstracts submission is open for SSO 2022 and SSO Advanced Cancer Therapies now through Monday, October 25, 2021! Review Abstract Site for more information!
Society of Surgical Oncology (SSO) President, Douglas S. Tyler, MD, MSHCT, FSSO, highlights ways SSO is working to ensure that members have access to valuable surgical oncology resources.
SSO’s Fellows Institute will take place virtually throughout the month of November. The meeting will feature networking opportunities and three specialty-specific tracks: Breast Surgical Oncology, Surgical Oncology and HPB. Sessions at Fellows Institute will include interactive lectures and cases plus discussions on how to get the most out of your fellowship, job selection and contracts.
SSO’s Fellows Institute is an annual educational program cosponsored by the Americas Hepato-Pancreato-Biliary Association (AHPBA) and the American Society of Breast Surgeons (ASBrS).
The SSO has produced the podcast, SurgOnc Today, featuring conversations with individuals who are experts within their respective fields and are members of the Society’s Disease Site Work Groups. SSO supports the need for treatment decisions to be made on a case-by-case basis. The surgeon’s knowledge and understanding of the biology of each cancer, alternative treatment options, and the institution’s policies at the time the patient will be scheduled for surgery all need to be taken into consideration.
SSO collaborated with the American Society of Clinical Oncology and the American Society for Radiation Oncology to develop, Management of Hereditary Breast Cancer: ASCO, ASTRO and SSO Guideline. The multidisciplinary, expert panel addressed 10 clinical practice questions in the guideline.
In addition, SSO’s Breast Disease Site Work Group Chair and Vice Chair published the following Editorial on the guideline. McGuire KP, Mamounas EP. Management of hereditary breast cancer: ASCO, ASTRO, and SSO Guideline. Ann Surg Oncol. 2020. https:doi.org/10.1245/s10434-020-08396-8.
Speaking of SurgOnc® is a podcast brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology (SSO). The series is hosted by ASO Deputy Editor Dr. Frederick L. (Rick) Greene, who expands upon ideas from articles published in the Annals of Surgical Oncology. Once a month, Dr. Greene interviews authors and leading experts in surgical oncology.
Plan to join colleagues at the SSO 2022 – International Conference on Surgical Cancer Care in Hilton Anatole, Dallas, TX.
MARCH 9-12, 2022
ExpertEd@SSO is your source for premier continuing education with programs.